Q1 2024 · 13F-HR
ACUTA CAPITAL PARTNERS, LLCholdings as filed
Filed 2024-05-15 · accession 0001104659-24-061603
$153.9M
Reported value
33
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $24.0M | 15.6% | 2,635,287 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $9.9M | 6.43% | 162,302 | Common | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $9.7M | 6.30% | 2,164,628 | Common | SOLE |
| 877619106 | TSHA | TAYSHA GENE THERAPIES INC | $9.6M | 6.21% | 3,333,333 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $8.8M | 5.72% | 326,787 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $8.3M | 5.40% | 64,162 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $7.2M | 4.65% | 104,830 | Common | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $7.0M | 4.53% | 396,099 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $6.0M | 3.88% | 261,108 | Common | SOLE |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $5.4M | 3.50% | 792,000 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $5.2M | 3.40% | 184,500 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $4.8M | 3.11% | 76,800 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $4.6M | 3.01% | 143,777 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC | $4.6M | 2.97% | 109,000 | Common | SOLE |
| 00032Q104 | WHWK | AADI BIOSCIENCES INC | $4.3M | 2.81% | 1,849,402 | Common | SOLE |
| 43157M102 | — | HILLEVAX INC | $4.2M | 2.71% | 250,609 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS | $3.7M | 2.38% | 78,403 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $3.5M | 2.27% | 199,433 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $3.1M | 1.98% | 465,079 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $3.0M | 1.94% | 92,346 | Common | SOLE |
| 92337C203 | VSTM | VERASTEM INC | $2.4M | 1.59% | 207,095 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $2.4M | 1.56% | 34,500 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC. | $1.9M | 1.25% | 90,000 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $1.7M | 1.09% | 61,718 | Common | SOLE |
| 00847X104 | AGIO | AGIOS PHARMA | $1.6M | 1.05% | 55,262 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $1.4M | 0.93% | 103,992 | Common | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $1.3M | 0.85% | 397,884 | Common | SOLE |
| 55234L105 | LYRAGBP | LYRA THERAPEUTICS INC | $1.1M | 0.70% | 173,320 | Common | SOLE |
| 52187K200 | CYPH | LEAP THERAPEUTICS INC | $942,082 | 0.61% | 354,166 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL INC | $933,800 | 0.61% | 20,000 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC. | $920,360 | 0.60% | 13,300 | Common | SOLE |
| 15117F807 | CLRBUSD | CELLECTAR BIOSCIENCES INC. | $571,130 | 0.37% | 143,500 | Common | SOLE |
| 67080N119 | NUVB/WS | NUVATION BIO | $27,477 | 0.02% | 90,832 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.